Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportRadiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET

Fumihiko Yamamoto, Ryo Yamahara, Kensuke Kurihara, Hideo Tsukada, Eri Takeuchi, Isao Hara, Akira Makino, Shinae Kizaka-Kondoh, Eiichi Ozeki and Shunsaku Kimura
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1509;
Fumihiko Yamamoto
1Translational Research Center, Kyoto University Hospital, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ryo Yamahara
2Technology Research Laboratory, Shimadzu Corporation, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kensuke Kurihara
1Translational Research Center, Kyoto University Hospital, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideo Tsukada
3Central Research Laboratory, Hamamatsu Photonics K.K., Hamamatsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eri Takeuchi
2Technology Research Laboratory, Shimadzu Corporation, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isao Hara
2Technology Research Laboratory, Shimadzu Corporation, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Makino
4Graduate School of Engineering, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shinae Kizaka-Kondoh
5Graduate School of Medicine, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eiichi Ozeki
2Technology Research Laboratory, Shimadzu Corporation, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shunsaku Kimura
4Graduate School of Engineering, Kyoto University, Kyoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1509

Objectives We have developed amphiphilic polydepsipeptide micelle "Lactosome" as a novel nanocarrier with tumor accumulation property by the enhanced permeability and retention effect for cancer imaging probes. We reported previously that a near infrared fluorescent (NIRF) imaging of mouse tumor with using ICG-lactosome. In this study, with aim of developing radiotracers for in vivo tumor imaging by PET, 18F-lactosome was synthesized and evaluated.

Methods As a containable molecule into the lactosome, 18F labeled polylactic acid (18F-BzPLA) was synthesized in 20-37 % EOB by coupling reaction of SFB connected at an amino group terminal of polylactic acid. Micelle assemblies were prepared from a mixture of 18F-BzPLA and the amphiphilic polymer by a film method. For biodistribution studies, BALB/cA Jcl-nu/nu mice bearing HeLa cells in femur region were used. We took images by both PET and NIRF images of tumor bearing mice after co-injected 18F-lactosome with ICG-lactosome by using both Clairvivo PET and Clairvivo OPT (Shimadzu Corp. Japan) respectively.

Results 18F-Lactosome was prepared in good yields (222-420 MBq). The radioactivity of 18F-lactosome was found to be stable in a blood circulation and maintained to higher level during 10 min to 6 hrs after injection. Tumor uptake increased gradually after injection. The mean uptake ratios of tumor/muscle, tumor/digestive tract and tumor/brain were 2.7, 2.8 and 4.9 at 6 hrs. In addition, tumor PET imaging of 18F-lactosome was capable and similar to NIRF imaging by ICG-lactosome.

Conclusions Tumor imaging by PET with using lactosome as a nanocarrier is therefore a potential candidate for a facile and general tumor imaging technique

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
Fumihiko Yamamoto, Ryo Yamahara, Kensuke Kurihara, Hideo Tsukada, Eri Takeuchi, Isao Hara, Akira Makino, Shinae Kizaka-Kondoh, Eiichi Ozeki, Shunsaku Kimura
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1509;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
Fumihiko Yamamoto, Ryo Yamahara, Kensuke Kurihara, Hideo Tsukada, Eri Takeuchi, Isao Hara, Akira Makino, Shinae Kizaka-Kondoh, Eiichi Ozeki, Shunsaku Kimura
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 1509;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
  • Novel probes targeting urokinase plasminogen activator (uPA) for imaging metastatic potential
Show more Radiopharmaceutical Chemistry: New Radiopharmaceuticals-Novel Probe Development

New Radiopharmaceuticals-Novel Probe Development Posters

  • [11C]Dimebon as a new PET agent for imaging of Alzheimer’s disease and Huntington’s disease
  • Novel probes targeting urokinase plasminogen activator (uPA) for imaging metastatic potential
  • Development and initial evaluation of novel fluorine-18 labeled nanocarrier "Lactosome" as a tumor imaging probe for PET
Show more New Radiopharmaceuticals-Novel Probe Development Posters

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire